Possible Associations of Acut Hepatitis B With New-onset Type 1 Diabetes: A Case Report

Authors

  • Nesibe Akyürek
  • Mehmet Emre Atabek
  • Beray Selver Eklioğlu

Abstract

Type 1 diabetes (T1D) results from the destruction of pancreatic beta cells, and genetic and environmental factors are believed to be the major components in the development of the disease. Viruses have long been suspected to contribute to the onset of T1D. Hepatitis B (HBV) is associated with the development of autoimmunity. We describe a case of type 1 diabetes that was triggered by HBV.

References

International Agency for Research on Cancer. Hepatitisviruses. IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon IARC 1994; 59.

Kuper H, Tozonou A, and Kaklamani E. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000; 85:498-502.

Lawson DH, Gray JMB, McKillop C, Clarke J, Lee FD et al. Diabetes mellitus and primary hepatocellular carcinoma.Q J Med 1986; 61:945-55.

Jun HS, Yoon JW A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev 2003;19:8–31

Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006;28:112–25.

Nagao Y, Hanada S, Shishido S, Ide T, Kumashiro R, Ueno T et al. Incidence of Sjogren’s syndrome in Japanese patients with hepatitis C virus infection.2003; J Gastroenterol Hepatol 18:258–66.

Permin H, Aldershvile J, Nielsen JO Hepatitis B virus infection in patients with rheumatic diseases. Ann Rheum Dis1982;41:479–82.

Kansu A, Kuloglu Z, Demirceken F, Girgin N . Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha. Turk J Gastroenterol 2004;15:213–8.

Murakami C, Hino K, Okazaki M, Fujii K, Okuda M, Hanada H et al. Hepatitis B virus carrier status linked to autoimmunen hepatitis. Intern Med 1996;35:468–71.

Bogdanos DP, Mieli-Vergani G, Vergani D .Virus, liver and autoimmunity. Dig Liver Dis 2000;32:440–6.

Baumert TF, Thimme R, von Weizsacker F .Pathogenesis of hepatitis B virus infection. World J Gastroenterol 2007;13:82–90.

Wucherpfennig KW Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 2001;108:1097–104.

Looi LM, Prathap K Hepatitis B virus surface antigen in glomerular immune complex deposits of patients with systemic lupus erythematosus. Histopathology 1982;6:141–7.

Lai KN, Lai FM, Chan KW, Chow CB, Tong KL, Vallance-Owen J The clinico pathologic features of hepatitis B virus associated glomerulonephritis. Q J Med1987; 63:323–33.

Chi ZC, Ma SZ Rheumatologic manifestations of hepatic diseases. Hepatobiliary Pancreat Dis Int 2003;2:32–7.

Khuri KG, Shamma’a MH, Abourizk N (1985) Hepatitis B virus markers in diabetes mellitus. Diabetes Care 1985;8:250–3.

Halota W, Muszynska M, Pawlowska M Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes. Med Sci Monit 2002;8:CR516–CR519.

Downloads

Published

14.04.2015

Most read articles by the same author(s)